title: p53 directly represses Id2 to inhibit the proliferation of neural progenitor cells.
abstract: Neural progenitor cells (NPCs) have the capacity to proliferate and give rise to all major central nervous system cell types and represent a possible cell of origin in gliomagenesis. Deletion of the tumor suppressor gene Tp53 (p53) results in increased proliferation and self-renewal of NPCs and is a common genetic mutation found in glioma. We have identified inhibitor of DNA binding 2 (Id2) as a novel target gene directly repressed by p53 to maintain normal NPC proliferation. p53((-/-)) NPCs express elevated levels of Id2 and suppression of Id2 expression is sufficient to inhibit the increased proliferation and self-renewal which results from p53 loss. Elevated expression of Id2 in wild-type NPCs phenocopies the behavior of p53((-/-)) NPCs by enhancing NPC proliferation and self-renewal. Interestingly, p53 directly binds to a conserved site within the Id2 promoter to mediate these effects. Finally, we have identified elevated Id2 expression in glioma cell lines with mutated p53 and demonstrated that constitutive expression of Id2 plays a key role in the proliferation of glioma stem-like cells. These findings indicate that Id2 functions as a proproliferative gene that antagonizes p53-mediated cell cycle regulation in NPCs and may contribute to the malignant proliferation of glioma-derived tumor stem cells.
authors: Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, New Hampshire, USA. brenton.r.paolella@dartmouth.edu
authors: Brenton R
authors: BR
authors: Paolella
authors: Matthew C
authors: MC
authors: Havrda
authors: Akio
authors: A
authors: Mantani
authors: Christina M
authors: CM
authors: Wray
authors: Zhonghua
authors: Z
authors: Zhang
authors: Mark A
authors: MA
authors: Israel
references: Bioinformatics. 2000 Nov;16(11):1046-7
references: 11159318
references: Nat Rev Cancer. 2009 Oct;9(10):714-23
references: 19730431
references: Nature. 2008 Oct 23;455(7216):1129-33
references: 18948956
references: Nat Rev Mol Cell Biol. 2008 May;9(5):402-12
references: 18431400
references: Nat Neurosci. 2009 Nov;12(11):1398-406
references: 19838178
references: J Neurosci. 2006 Jan 25;26(4):1107-16
references: 16436596
references: Cancer Res. 2008 Jan 15;68(2):415-24
references: 18199535
references: Cancer Res. 2003 Aug 1;63(15):4305-9
references: 12907595
references: Oncogene. 2008 May 1;27(20):2897-909
references: 18037961
references: Development. 2000 Jul;127(14):3021-30
references: 10862740
references: Nat Rev Cancer. 2005 Aug;5(8):603-14
references: 16034366
references: Stem Cells. 2009 Jul;27(7):1473-86
references: 19544453
references: Cancer Cell. 2006 May;9(5):391-403
references: 16697959
references: Science. 2001 Dec 7;294(5549):2186-9
references: 11691952
references: Cancer Cell. 2009 Apr 7;15(4):315-27
references: 19345330
references: Cancer Cell. 2010 Jan 19;17(1):98-110
references: 20129251
references: J Biol Chem. 2002 Mar 15;277(11):9118-26
references: 11756408
references: Cancer Res. 1988 Sep 15;48(18):5358-62
references: 3409256
references: Cancer Res. 1999 Apr 1;59(7 Suppl):1726s-1730s
references: 10197587
references: Biophys Chem. 2002 Dec 10;101-102:611-23
references: 12488030
references: Cancer Cell. 2009 Jan 6;15(1):45-56
references: 19111880
references: Science. 1998 Nov 20;282(5393):1497-501
references: 9822382
references: Nature. 2004 Nov 18;432(7015):396-401
references: 15549107
references: Cell Cycle. 2010 Mar 1;9(5):870-9
references: 20160511
references: Cell Stem Cell. 2009 Jun 5;4(6):568-80
references: 19497285
references: Mol Cell Biol. 1996 Jun;16(6):2570-8
references: 8649364
references: J Neurosci. 2008 Dec 24;28(52):14074-86
references: 19109490
references: Cancer Res. 2008 Aug 15;68(16):6789-96
references: 18701504
references: Cancer Biol Ther. 2008 May;7(5):699-708
references: 18277095
references: Cold Spring Harb Perspect Biol. 2010 Feb;2(2):a001107
references: 20182618
references: Dev Biol. 1996 Apr 10;175(1):1-13
references: 8608856
references: Science. 1996 Feb 16;271(5251):978-81
references: 8584933
references: Cell. 2009 Sep 18;138(6):1083-95
references: 19766563
references: Development. 2004 Sep;131(17):4131-42
references: 15280210
references: Development. 2004 Nov;131(21):5441-8
references: 15469968
references: J Biol Chem. 1998 Dec 11;273(50):33533-9
references: 9837934
references: Hum Mol Genet. 1994 Sep;3(9):1537-42
references: 7833908
references: Cell Cycle. 2010 Jun 15;9(12):2464-6
references: 20519942
references: Genes Dev. 2001 Aug 1;15(15):1913-25
references: 11485986
references: Nature. 2008 Oct 23;455(7216):1061-8
references: 18772890
references: Cancer Cell. 2009 Jun 2;15(6):514-26
references: 19477430
references: Int J Cancer. 1983 Jan 15;31(1):13-20
references: 6339421
references: Genes Dev. 1994 Jun 1;8(11):1270-84
references: 7926730
references: Cell. 1990 Apr 6;61(1):49-59
references: 2156629
references: J Biol Chem. 2000 Oct 27;275(43):33593-600
references: 10915795
references: Cell. 1999 Jun 11;97(6):703-16
references: 10380923
references: Development. 2006 Jan;133(2):363-9
references: 16368933
references: Nat Genet. 1992 Apr;1(1):45-9
references: 1301998
references: Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14373-8
references: 19597154
references: Curr Biol. 1994 Jan 1;4(1):1-7
references: 7922305
references: J Biol Chem. 2002 Feb 1;277(5):3247-57
references: 11714700
references: Cancer Cell. 2010 Apr 13;17(4):362-75
references: 20385361
references: Stem Cells Dev. 2010 Jun;19(6):831-41
references: 19757990